Results 101 to 110 of about 19,471 (205)

Prevention of Skin Carcinogenesis by the b-Blocker Carvedilol

open access: yes, 2020
The stress-related catecholamine hormones and the a-and b-adrenergic receptors (a-and b-AR) may affect carcinogenesis. The b-AR GRK/b-arrestin biased agonist carvedilol can induce b-AR-mediated transactivation of the EGFR.
Mandy M Liu   +10 more
core  

Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure

open access: yesКардиоваскулярная терапия и профилактика, 2008
Aim. To assess carvedilol and bisoprolol effects on clinical symptoms, hemodynamics and morpho-functional heart characteristics in patients with myocardial infarction (MI) and chronic heart failure (CHF).Material and methods.
A. I. Chesnikova   +3 more
doaj  

Is carvedilol superior to propranolol in patients with cirrhosis with portal hypertension: a systematic and meta-analysis

open access: yesDrugs in Context
Background: Carvedilol has shown greater potency than propranolol as a β-blocker in managing cardiac conditions. However, its efficacy in reducing portal hypertension (PHTN) in patients with cirrhosis remains unclear.
Siddheesh Rajpurohit   +4 more
doaj   +1 more source

Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity

open access: yesCell Reports
Summary: The stimulator of interferon genes (STING)-mediated type I interferon (IFN) response is critical for mounting anti-tumor immunity and sensitizing chemotherapy by remodeling the tumor immune microenvironment.
Yifang Dang   +14 more
doaj   +1 more source

Carvedilol therapy in pediatric patients with dilated cardiomyopathy [PDF]

open access: yes, 2009
Carvedilol reduces mortality and hospitalization in adults with congestive heart failure. Limited information is available about its use in children. The objective of this study was to determine the dosing, efficacy and side effects of carvedilol for the
Ozlem M Bostan   +3 more
core  

Carvedilol treatment for aortic valve regurgitation

open access: yes, 2011
Background — Aortic regurgitation (AR) is a chronic disease for which there is currently no approved medical treatment. We previously reported in an animal model that β-blockade with metoprolol exerted beneficial effects on left ventricular remodeling ...
Roussel, Élise   +9 more
core   +1 more source

Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)

open access: yes, 2004
Background: Management guidelines for heart failure recommend ACE-I and beta-blockers. The perception of difficult up-titration might have added to the slow uptake of beta-blockers despite their mortality and morbidity benefits.
Jaarsma, Wybren   +34 more
core   +1 more source

Carvedilol atenua o estresse oxidativo na cardiopatia chagásica crônica Carvedilol atenúa el estrés oxidativo en la cardiopatía chagásica crónica Carvedilol attenuates oxidative stress in chronic chagasic cardiomyopathy

open access: yes, 2012
FUNDAMENTO: Há cada vez mais evidências sugerindo que doença de Chagas envolve dano oxidativo e contribui para a progressão da doença cardíaca. OBJETIVO: Avaliar o efeito do carvedilol sobre marcadores de estresse oxidativo na doença de Chagas crônica ...
Edésio Luiz Simionato   +9 more
core  

Effect of empagliflozin with or without carvedilol on tricuspid regurgitation and right ventricular remodeling: PROVE trial. [PDF]

open access: yesJ Cardiovasc Imaging
Kim GY   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy